文献速递颈动脉与弓上血管

心房颤动患者颈动脉血运重建手术的安全性

Safety of carotid artery revascularization procedures in patients with atrial fibrillation.
PubMed 文献 · J Vasc Surg · 2020-05-26

基于Premier医疗数据库2009-2015年86,778例颈动脉内膜切除术或颈动脉支架置入术患者,其中心房颤动占7.8%。心房颤动与更高的院内死亡、脑出血及卒中/死亡风险相关,且有症状心房颤动患者卒中/死亡风险高于指南推荐阈值,颈动脉内膜切除术总体优于颈动脉支架置入术。

要点

  • 心房颤动患者颈动脉血运重建后死亡和卒中/死亡风险显著升高。
  • 有症状心房颤动患者卒中/死亡风险高于指南推荐的可接受范围。
  • 心房颤动患者中颈动脉内膜切除术的围术期脑出血、死亡和卒中/死亡风险低于颈动脉支架置入术。

核心结论

  • 心房颤动与颈动脉疾病患者术后更差结局相关,有症状心房颤动患者卒中/死亡风险高于指南推荐,颈动脉内膜切除术总体优于颈动脉支架置入术。

研究设计与样本

  • 回顾性队列研究,查询Premier医疗数据库2009-2015年,纳入86,778例接受颈动脉内膜切除术或颈动脉支架置入术的患者。

主要发现

  • 心房颤动患者占7.8%(6743例),无症状患者占94.6%(82,128例)。
  • 无症状患者中心房颤动 vs 非心房颤动:死亡率0.4% vs 0.2%,卒中/死亡1.7% vs 1.2%(均P < .05)。
  • 有症状患者中心房颤动 vs 非心房颤动:死亡率6.9% vs 2.1%,卒中/死亡10.6% vs 4.5%(均P < .05)。
  • 校正分析显示心房颤动患者脑出血aOR 1.29(95%CI 1.00-1.67)、死亡aOR 1.59(95%CI 1.11-2.26)、卒中/死亡aOR 1.30(95%CI 1.08-1.58)。
  • 心房颤动患者中卒中/死亡的预测因素包括颈动脉支架置入术(aOR 1.80,95%CI 1.21-2.68)和有症状表现(aOR 5.00,95%CI 3.20-7.83)。

关键数值与推荐

  • 心房颤动患者缺血性卒中多变量分析aOR 1.17(95%CI 0.93-1.47),未达统计学显著性。
  • 心房颤动患者卒中/死亡的其他预测因素包括术前用药类型、年龄和医院规模。

临床怎么用

  • 在心房颤动合并颈动脉疾病患者中,选择血运重建方式时应考虑颈动脉内膜切除术可能优于颈动脉支架置入术。
  • 对有症状心房颤动患者行颈动脉支架置入术需谨慎评估,因其卒中/死亡风险较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atrial fibrillation (Afib) is a major contributor to cerebrovascular events. Coexisting carotid artery disease is not uncommon in Afib patients, yet they have been excluded from major randomized clinical trials. Therefore, the aim of this study was to evaluate the safety of carotid endarterectomy (CEA) and carotid artery stenting (CAS) in Afib patients. METHODS: The Premier Healthcare Database was queried (2009-2015). Patients who underwent CEA or CAS were captured by International Classification of Diseases, Ninth Revision, Clinical Modification codes. Multivariable logistic modeling was implemented to examine the outcomes: in-hospital stroke, intracerebral hemorrhage (ICH), mortality, and stroke/death. RESULTS: There were 86,778 patients included. The majority were asymptomatic (n = 82,128 [94.6%]). Afib was reported in 6743 patients (7.8%). In terms of absolute outcomes in both asymptomatic and symptomatic patients, Afib patients (vs non-Afib patients) had higher mortality and stroke/death (asymptomatic: mortality, 0.4% vs 0.2%; stroke/death, 1.7% vs 1.2%; symptomatic: mortality, 6.9% vs 2.1%; stroke/death, 10.6% vs 4.5%; all P < .05). Adjusted analysis yielded higher odds of ICH (adjusted odds ratio [aOR], 1.29; 95% confidence interval [CI], 1.00-1.67), mortality (aOR, 1.59; 95% CI, 1.11-2.26), and stroke/death (aOR, 1.30; 95% CI, 1.08-1.58) in Afib patients. Although univariable analysis found Afib to be a statistically significant predictor of ischemic stroke, similar results could not be elucidated in the multivariable analysis (aOR, 1.17; 95% CI, 0.93-1.47). In Afib patients, important predictors of stroke/death included CAS (aOR, 1.80; 95% CI, 1.21-2.68) and symptomatic presentation (aOR, 5.00; 95% CI, 3.20-7.83). Other important predictors were type of preoperative medication use, age, and hospital size. CONCLUSIONS: Afib was associated with worse postoperative outcomes in patients with carotid artery disease. Symptomatic status in Afib patients is associated with a stroke/death risk that is higher than in recommended guidelines for CEA and particularly for CAS. Overall, CEA was associated with lower periprocedural ICH, mortality, and stroke/death in Afib patients compared with CAS.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nejim B, Mathlouthi A, Weaver L, et al. Safety of carotid artery revascularization procedures in patients with atrial fibrillation. J Vasc Surg. 2020. PMID: 32471737. doi:10.1016/j.jvs.2020.01.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。